Monopar Therapeutics（MNPR）内部人交易：高管与董事近期交易
过去 18 个月，共有 13 位内部人为 Monopar Therapeutics（MNPR）报告了 79 笔 Form 4 交易（最近一笔 2026-10-05）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-05 | STARR CHRISTOPHER M | 董事 | 买入 | 8,400 | $42 |
| 2026-10-05 | STARR CHRISTOPHER M | 董事 | 卖出 | 4,631 | $361,635 |
| 2026-10-05 | STARR CHRISTOPHER M | 董事 | 卖出 | 2,970 | $234,095 |
| 2026-10-05 | STARR CHRISTOPHER M | 董事 | 卖出 | 799 | $63,656 |
| 2026-10-02 | Robinson Chandler | Chief Executive Officer | 买入 | 9,801 | $0 |
| 2026-10-02 | Cittadine Andrew | Chief Operating Officer | 买入 | 4,384 | $0 |
| 2026-10-02 | Vu Quan Anh | Chief Financial Officer | 买入 | 614 | $0 |
| 2026-10-02 | Robinson Chandler | Chief Executive Officer | 卖出 | 4,344 | $346,086 |
| 2026-10-02 | Cittadine Andrew | Chief Operating Officer | 卖出 | 1,944 | $154,878 |
| 2026-10-02 | Vu Quan Anh | Chief Financial Officer | 卖出 | 180 | $14,341 |
| 2026-09-28 | Robinson Chandler | Chief Executive Officer | 卖出 | 10,450 | $910,718 |
| 2026-09-28 | Robinson Chandler | Chief Executive Officer | 买入 | 15,000 | $210,000 |
| 2026-09-28 | Robinson Chandler | Chief Executive Officer | 买入 | 14,056 | $421,680 |
| 2026-09-28 | Robinson Chandler | Chief Executive Officer | 卖出 | 9,638 | $847,758 |
| 2026-09-28 | Robinson Chandler | Chief Executive Officer | 卖出 | 8,368 | $744,501 |
| 2026-09-28 | Robinson Chandler | Chief Executive Officer | 卖出 | 600 | $53,874 |
| 2026-08-28 | Tsuchimoto Kim R | 董事 | 买入 | 2,055 | $61,650 |
| 2026-08-28 | Anderson Raymond | 董事 | 买入 | 1,402 | $42,060 |
| 2026-08-28 | Tsuchimoto Kim R | 董事 | 买入 | 2,035 | $28,490 |
| 2026-08-28 | Anderson Raymond | 董事 | 买入 | 1,740 | $52,200 |
| 2026-08-28 | Tsuchimoto Kim R | 董事 | 卖出 | 485 | $52,783 |
| 2026-08-28 | Anderson Raymond | 董事 | 卖出 | 694 | $76,368 |
| 2026-08-28 | Tsuchimoto Kim R | 董事 | 卖出 | 615 | $67,379 |
| 2026-08-28 | Anderson Raymond | 董事 | 卖出 | 646 | $71,751 |
| 2026-08-28 | Tsuchimoto Kim R | 董事 | 卖出 | 700 | $77,455 |
来源：SEC Form 4 申报文件 · 截至 2026-10-05